SCHEMBL16334358

SCHEMBL16334358

COc1ccc2c(c1)OC(=O)CC2=O

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.51
CYP19A1 P11511 6/20 0.51
CYP3A4 P08684 1/20 0.51
CA12 O43570 2/20 0.51
CA9 Q16790 2/20 0.51
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CA2 P00918 1/20 0.48
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
PTGS2 P35354 1/20 0.46
METAP1 P53582 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26767255 0.84 METAP1 (0.54) MAOBCYP19A1CA12CA9ALDH1A1
SCHEMBL14069462 0.84 METAP1 (0.50) MAOBCYP19A1CYP3A4ALDH1A1KDM4E
SCHEMBL31525565 0.79 CA12 (0.54) CA12CA9ALDH1A1KDM4ESMN1; SMN2
SCHEMBL14495775 0.79 CA12 (0.54) CA12CA9ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10963283 0.78 MAOB (0.52) MAOBCYP19A1CYP3A4ALDH1A1KDM4E
SCHEMBL26768004 0.76 METAP1 (0.49) MAOBCYP19A1CA12CA9ALDH1A1
SCHEMBL26767999 0.76 METAP1 (0.49) MAOBCYP19A1CA12CA9ALDH1A1
SCHEMBL31689707 0.76 MAPT (0.59) MAOBCYP19A1CYP3A4ALDH1A1KDM4E
SCHEMBL68899 0.76 MAPT (0.59) MAOBCYP19A1CYP3A4ALDH1A1KDM4E
SCHEMBL5369640 0.76 MAOA (0.56) MAOBCA12CA9ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013832-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF Merck Patent GmbH (DE) 2016-05-04 EP disclosed
WO-2014209980-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2014-12-31 WO disclosed